Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Congenital atransferrinemia]

A Hromec1, J Payer, Z Killinger

  • 1I Medizinische Klinik, Komenský-Universität Bratislava.

Deutsche Medizinische Wochenschrift (1946)
|May 6, 1994
PubMed
Summary

Congenital atransferrinemia, a rare genetic disorder, requires early diagnosis and consistent treatment. This case highlights how even regular treatment can lead to complications like haemosiderosis if not optimized.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transforming post-STEMI care: The IMPACS study design and baseline patient profile.

International journal of cardiology·2026
Same author

Myocardial fibrosis, the silent instigator of diastolic dysfunction in patients with rheumatoid arthritis.

Physiological research·2025
Same author

Parathyroid Hormone-Related Changes of Bone Structure.

Physiological research·2022
Same author

Fibroblast Growth Factor 23 and Klotho Are Associated With Trabecular Bone Score but Not Bone Mineral Density in the Early Stages of Chronic Kidney Disease: Results of the Cross-Sectional Study.

Physiological research·2022
Same author

Prediction of Vertebral Fractures by Trabecular Bone Score in Patients With Ankylosing Spondylitis.

Physiological research·2022
Same author

The Long-Term Effects of Growth Hormone Replacement on Bone Mineral Density and Trabecular Bone Score: Results of the 10-Year Prospective Follow-up.

Physiological research·2022

Area of Science:

  • Hematology
  • Genetics
  • Pediatrics

Background:

  • Congenital atransferrinemia is a rare inherited disorder of iron metabolism.
  • It is characterized by severe iron deficiency anemia and iron overload in tissues.

Observation:

  • A 27-year-old woman diagnosed with congenital atransferrinemia at 11 months.
  • Received irregular and inadequate human transferrin treatment until age 14.
  • Subsequently received regular human transferrin (1g monthly) and deferoxamine (500mg twice weekly).

Findings:

  • Despite regular treatment, the patient developed haemosiderosis affecting multiple organs including the heart, liver, hypophysis, thyroid, and locomotor system.
  • This indicates potential limitations of current treatment protocols in preventing iron overload.

Implications:

  • Emphasizes the critical need for early diagnosis and optimized treatment strategies for congenital atransferrinemia.
  • Highlights the importance of monitoring for and preventing complications such as haemosiderosis.
  • Suggests further research into more effective therapeutic interventions for this rare condition.

Related Experiment Videos